Drug Type Monoclonal antibody |
Synonyms |
Target |
Mechanism IGSF8 modulators(immunoglobulin superfamily member 8 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Solid tumor | Phase 1 | - | 28 Jun 2023 |